Lipid nanoemulsions for anti-cancer drug therapy

Pharmazie

Volumn 66, Issue 7, 2011, Pages 473-478

  Souto, Eliana B ^a,b   Nayak, A P ^c   Murthy, R S R ^d  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^d ISF COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORON; CELECOXIB; CREMOPHOR; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; DRUG CARRIER; GADOLINIUM; PACLITAXEL; SMALL INTERFERING RNA; TAMOXIFEN; NANOPARTICLE;

CANCER THERAPY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SOLUBILITY; ENTROPY; HUMAN; HYDROPHOBICITY; LIPID NANOEMULSION; LIPOPHILICITY; LIPOSOMAL DELIVERY; NANOEMULSION; NEUTRON CAPTURE THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; THERMODYNAMICS; ANIMAL; ARTICLE; CHEMISTRY; EMULSION; NEOPLASM;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; NANOPARTICLES; NEOPLASMS; RNA, SMALL INTERFERING;

EID: 80051926177     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0392     Document Type: Review

References (50)

1. Aditya NP, Souto ESF, Murthy RSR, Souto EB (2011) Past, Present and Future of Lipid Nanoparticles in Cancer Therapy. in Souto EB (ed) Lipid Nanocarriers in Cancer Diagnosis and Therapy, i-Smithers - Creative Publishing Solutions, Chapter 2, pp 11-27.
2. Ansari MJ, Kohli K, Dixit N (2008) Microemulsions as potential drug delivery systems: a review. PDA J Pharm Sci Technol 62: 66-79.
3. Beg S, Javed S, Kohli K (2010) Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat Drug Deliv Formul 4: 245-255.
4. Boonme P, Krauel K, Graf A, Rades T, Junyaprasert VB (2006) Characterization of microemulsion structures in the pseudoternary phase diagram of isopropyl palmitate/water/Brij 97:1-butanol. AAPS PharmSciTech 7: E45.
5. Broerse JJ, Barendsen GW (1967) Measurements of biological effects and physical parameters of neutrons from the 9Be(3He,n)11C reaction; possibilities for fast neutron radiotherapy. Int J Radiat Biol Relat Stud Phys Chem Med 13: 189-194.
6. Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2: 711-719. (Pubitemid 44764213)
7. Cevc G, Vierl U (2010) Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Control Release 141: 277-299.
8. Changez M, Varshney M, Chander J, Dinda AK (2006) Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloids Surf B Biointerfaces 50: 18-25. (Pubitemid 43794900)
9. Chen H, Khemtong C, Yang X, Chang X, Gao J (2010) Nanonization strategies for poorly water-soluble drugs. Drug Discov Today, in press.
10. Clasen B (1990) [Principles of therapy with fission neutrons and boron neutron capture therapy for radioresistant head-neck malignancies]. Laryngorhinootologie 69: 433-436.
11. Constantinides PP, Tustian A, Kessler DR (2004) Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 56: 1243-1255. (Pubitemid 38510472)
12. Dreher F, Walde R, Walther R, Wehrli E (1997) Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 45: 131-140. (Pubitemid 27065215)
13. Eccleston J (1995) Microemulsions, in: "Encyclopedia of Pharmaceutical Technology" Swarbrick J, Boylan JC (editors), Newyork: Marcel Dekker, 9: 375-421.
14. Fang JY, Hung CF, Hua SC, Hwang TL (2009) Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. Ultrasonics 49: 39-46.
15. Fraga M, Laux M, Dos Santos GR, Zandona B, Dos Santos Giuberti C, de Oliveira MC, da Silveira MU, Teixeira HF (2008) Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay. Pharmazie 63: 667-670.
16. Hagigit T, Abdulrazik M, Orucov F, Valamanesh F, Lambert M, Lambert G, Behar-Cohen F, Benita S (2010) Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGFKD Rreceptors to the eye. J Control Release 145: 297-305.
17. Hagigit T, Nassar T, Behar-Cohen F, Lambert G, Benita S (2008) The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. Eur J Pharm Biopharm 70: 248-259.
18. He CX, He ZG, Gao JQ (2010) Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin Drug Deliv 7: 445-460.
19. Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y (2007) Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy. Curr Drug Deliv 4: 131-140. (Pubitemid 46557489)
20. Izquierdo P, Esquena J, Tadros TF, Dederen JC, Feng J, Garcia-Celma MJ, Azemar N, Solans C (2004) Phase behavior and nano-emulsion formation by the phase inversion temperature method. Langmuir 20: 6594-6598.
21. Jain KK (2006) Commercial potential of RNAi. Mol Biosyst 2: 523-526.
22. Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Muller RH (2009) Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm 377: 207-214.
23. Kaneda MM, Sasaki Y, Lanza GM, Milbrandt J, Wickline SA (2010) Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. Biomaterials 31: 3079-3086.
24. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J Control Release 81: 65-74. (Pubitemid 34454850)
25. Khandavilli S, Panchagnula R (2007) Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J Invest Dermatol 127: 154-162. (Pubitemid 46005673)
26. Khurana B, Goyal AK, Budhiraja A, Arora D, Vyas SP (2010) siRNA delivery using nanocarriers - an efficient tool for gene silencing. Curr Gene Ther 10: 139-155.
27. Klang V, Matsko N, Zimmermann AM, Vojnikovic E, Valenta C (2010) Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm 393: 152-160.
28. Kommuru TR, Gurley B, Khan MA, Reddy IK (2001) Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212: 233-246. (Pubitemid 32119449)
29. Kong M, Park HJ (2011) Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydrate Res 83: 1303-1310.
30. McClements DJ, Li Y (2010) Structured emulsion-based delivery systems: controlling the digestion and release of lipophilic food components. Adv Colloid Interface Sci 159: 213-228.
31. Ozpolat B, Sood AK, Lopez-Berestein G (2010) Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med 267: 44-53.
32. Primo FL, Bentley MV, Tedesco AC (2008) Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. J Nanosci Nanotechnol 8: 340-347. (Pubitemid 351594266)
33. Rockwell S, Irvin CG, Nierenburg M (1986) Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice. Clin Exp Metastasis 4: 45-50. (Pubitemid 16106119)
34. Sarker DK (2005) Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2: 297-310.
35. Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG,Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M,Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ (2010) Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28: 172-176.
36. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S (2007) Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8: E104.
37. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008a) Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. J Drug Target 16: 733-740.
38. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S (2008b) Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnology 6: 8.
39. Shawer M, Greenspan P, S OI, Lu DR (2002) VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 91: 1405-1413. (Pubitemid 34633956)
40. Svensson H, Landberg T (1994) Neutron therapy-the historical background. Acta Oncol 33: 227-231.
41. Tadros T, Izquierdo P, Esquena J, Solans C (2004) Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108-109: 303-318.
42. Tagne JB, Kakumanu S, Ortiz D, Shea T, Nicolosi RJ (2008)Ananoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line. Mol Pharm 5: 280-286. (Pubitemid 351579131)
43. Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI (2008) Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2: 238-257.
44. Teicher BA (1992) Use of perfluorochemical emulsions in cancer therapy. Biomater Artif Cells Immobilization Biotechnol 20: 875-882.
45. Teicher BA, Herman TS, Frei E, 3rd (1992) Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation. Important Adv Oncol: 39-59.
46. Teo BS, Basri M, Zakaria MR, Salleh AB, Rahman RN, Rahman MB (2010) A potential tocopherol acetate loaded palm oil esters-in-water nanoemulsions for nanocosmeceuticals. J Nanobiotechnology 8: 4.
47. Tiwari S, Shenoy D (2006) Nanoemulsion Formulations for Improved Oral Delivery of Poorly Soluble Drugs. 9th Annual NSTI Nanotechnology Conference and Trade Show. Norheastern University. USA.
48. Tiwari SB, Amiji MM (2006) Nanoemulsion formulations for tumortargeted delivery, in: "Nanotechnology for Cancer Therapy" Mansoor M. Amiji (Editor). Florida: Taylor and Francis Group.
49. Tros de Ilarduya C, Sun Y, Duzgunes N (2010) Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci 40: 159-170.
50. Wooster TJ, Golding M, Sanguansri P (2008) Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 24: 12758-12765.